Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model

Thrombosis research

Volumn 134, Issue 3, 2014, Pages 729-736

  Herzog, Eva ^a   Kaspereit, Franz J ^a   Krege, Wilfried ^a   Doerr, Baerbel ^a   van Ryn, Joanne ^a   Dickneite, Gerhard ^a   Pragst, Ingo ^a  

^a CSL BEHRING GMBH   (Germany)

Author keywords

Anticoagulants; Antithrombins; Hemorrhage; Prothrombin complex concentrates; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; DABIGATRAN; DRUG COMBINATION; FACTOR IX, FACTOR VII, FACTOR X, PROTHROMBIN DRUG COMBINATION; HEMOSTATIC AGENT; PROTHROMBIN; THROMBIN;

ANIMAL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; CHEMICALLY INDUCED; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; FEMALE; HEMORRHAGE; METABOLISM; RABBIT; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; VENOUS THROMBOSIS;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DABIGATRAN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FACTOR IX; FACTOR VII; FACTOR X; FEMALE; HEMORRHAGE; HEMOSTATICS; PROTHROMBIN; RABBITS; RISK ASSESSMENT; RISK FACTORS; THROMBIN; TIME FACTORS; VENOUS THROMBOSIS;

EID: 85027938524     PISSN: None     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.07.003     Document Type: Article

References (0)